Argenx to present at upcoming investor conferences

August 28, 2024 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in september:
ARGX Ratings Summary
ARGX Quant Ranking